Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SAM-e Treatment of Depression in Parkinson's Disease.

Trial Profile

SAM-e Treatment of Depression in Parkinson's Disease.

Phase of Trial: Phase II/III

Latest Information Update: 14 Jul 2016

At a glance

  • Drugs Ademetionine (Primary) ; Escitalopram (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Dec 2009 Planned end date changed from 1 Oct 2009 to 1 Oct 2010 as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Planned number of patients changed from 100 to 80 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top